Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$181,637,122
+$180,409,552 QoQ
Shares Held
1,437,685
+16222.5% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#92
of 2,266 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$4,219,756
CallShares
33,400
PutValue
$1,048,622
PutShares
8,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. GILD ranks #1 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $181,637,122 | 1,437,685 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $4,219,756 | 33,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,048,622 | 8,300 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $1,728,188 | 12,400 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $6,787,319 | 48,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,227,570 | 8,808 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,253,272 | 42,800 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $2,062,032 | 16,800 | Put | Defined | 2026-02-17 | |
| 2025-06-30 | $18,263,393 | 164,728 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $57,227,968 | 510,736 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $8,403,750 | 75,000 | Put | Defined | 2025-07-21 | |
| 2024-12-31 | $79,129,407 | 856,657 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $13,855,500 | 150,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $193,273,836 | 2,305,270 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $35,136,896 | 512,125 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $26,194,200 | 357,600 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $45,113 | 602 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $3,865,157 | 46,585 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $34,725,301 | 562,900 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $7,431,250 | 125,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,305,000 | 500,000 | Put | Defined | 2022-02-14 | |
| 2021-03-31 | $117,202,885 | 1,813,444 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,663,451 | 612,143 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||